Other authors identified the PACSIN2 rs2413739 TT genotype as a significant risk factor for the development of mercaptopurine-induced hematological toxicity in ALL pediatric patients presenting the wild-type TPMT genotype (Smid et al, 2016). This evidence concerns the gene PACSIN2 and acute lymphoblastic leukemia.